HALO
Halozyme Therapeutics, Inc.
NASDAQUnited States
Market capitalizationUSD 12.0BAs of 8/28/2026, 11:59:59 PM
Halozyme Therapeutics, Inc. (HALO) is a publicly traded company listed on Nasdaq Stock Market and associated with United States. Its latest validated market capitalization is USD 12.0B. The latest available share price is $105.35. Institution currently ranks it #1,805 globally by market capitalization.
Global rank#1,805
Country rank#885United States
Share price$105.35end of day
Market capUSD 12.0B
Share price$105.35
1D change-1.47%
Price history
Adjusted historical share price · USDPrice history unavailableCurrent market data remains available while historical price coverage is prepared.
Company profile
Legal nameHALOZYME THERAPEUTICS, INC.
TickerHALO
Primary listingNasdaq Stock Market
CountryUnited States
Institution
Starting or running a U.S. company?
Institution coordinates incorporation, bookkeeping and tax preparation for modern businesses.